What Is-Juvenile Diabetes-Oakland-Type None Diabetes2016 09 18 18 22 08 34109420
All Video Credits are listed here http://broadcaster.beazil.net/public/credits/youtube/videos/41748 Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. We are JDRF – Juvenile Diabetes Research Foundation. We won’t stop until we create a world without T1D (type one diabetes). We are committed to eradicating type 1 diabetes and its effects for everyone with type 1, and at risk of developing it. T1D treatment options are improving all the time. We are driving research to improve the technology people with T1D use to monitor blood sugar levels and research that will ultimately deliver a cure.
Diabetes is a lifelong condition that causes a person’s blood sugar (glucose) level to become too high. The hormone insulin – is responsible for controlling the amount of glucose in the blood.
JDRF’s Mission: is to prevent and cure diabetes and to improve the lives of all people affected by this disease.
JDRF – the type 1 diabetes charity. Join the worldwide army of people who are making it their personal mission to fight type 1 diabetes. Together, we will create a world without type 1 diabetes. JDRF was founded in the New York area. Led by Lee Ducat, a group of local parents of children with T1D mobilized to raise money for diabetes research, and formed the first chapter of what was then known as the Juvenile Diabetes Foundation. A second chapter was founded shortly thereafter in Miami, Florida, followed by chapters in northern New Jersey and Washington, D.C. The fledgling organization was defined by its commitment to research funding. In addition to the high priority on funding T1D research, the organization’s founders resolved to inform the public about all aspects of T1D, advocate for more research funding from the federal government, and maintain the organization’s system of management by volunteer lay people. Since its inception, JDRF has evolved to become a worldwide leader in the fight against T1D. JDRF now has chapters and branches in most U.S. states, and international affiliates in several different countries. Star-gazing, stand-up paddle boarding, hikes through redwood forests—in Oakland? Absolutely. Get up close and personal with more than 450 species at the Oakland Zoo, bring out your inner science geek at Chabot Space & Science Center, and learn why Walt Disney was inspired to create Disneyland after a visit to Children’s Fairyland. Sure, it’s not what you expected. It’s Oakland, after all. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It seems important remind about the main points of that topic –
Health Care Providers,T1D,subcutaneous injection,UK Prospective Diabetes Study,VADT Trial,Lantus,permanent insulinopenia,diabetes diagnosis,Diabetes Control and Complications Trial,Kussmaul breathing,NDEP,Medical Device,Treating Type 1,diabetic,JDRF 2016,patient-driven care,(DCCT),insulin aspart,Clinical Trials,Celiac Disease and Diabetes,TrialNet,Device,insulin pumps,implantable insulin pump,insulin-dependent diabetes mellitus,Novolin N,Glucagon-like peptide 1 agonists,T1D community,Bolus Basel,alpha-glucosidase inhibitor,ADVANCE Trial,Inhaled Insulin,Pre- Diabetes,antihyperglycemic agents,Team Cure Diabetes,undiagnosed diabetes,ABCs of diabetes,A1C,Research Grants,DKA,Glipizide,Traveling with Diabetes,noninsulin monotherapy,T1D burden,low blood glucose,Online Diabetes Support Team,T1D management,Random Plasma Glucose Test,get involved,eAG,insulin dependent diabetes,volunteering,Research Progress,blood glucose meter,Insulin,ketone,Dymelor,blocking glucose reabsorption,cure,Insulin detemir,sugar breakdown,Severe hypoglycemia,American Diabetes Association,First time with insulin pump,turn Type One into Type.